Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06305637 · ClinicalTrials.gov registry record · Phase 1
A Study Comparing Ketoconazole Shampoo, 2% and Ketoconazole 2% Shampoo (RS) in the Treatment of Tinea Versicolor.
A Phase 1 study of Tinea Versicolor, sponsored by Sun Pharmaceutical Industries.
- Completed
- Registry status
- Phase 1
- Development phase
- 430
- Enrollment target
- 1
- Study location
NCT06305637 is a Phase 1 study of Tinea Versicolor that has completed, run by Sun Pharmaceutical Industries. The registered enrollment target is 430 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06305637, a Phase 1 study of Tinea Versicolor, has completed, sponsored by Sun Pharmaceutical Industries.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 430 participants
- Enrollment target
- 1
- Study location
Study Summary
To demonstrate the efficacy, therapeutic equivalence and safety of Ketoconazole Shampoo, 2% (Taro Pharmaceuticals U.S.A., Inc.) and Ketoconazole 2% Shampoo (Reference Standard) in the treatment of tinea versicolor.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Ketoconazole Shampoo, 2%
- DRUG Ketoconazole Shampoo, 2% (Reference Standard)
Study Locations (1)
New York
- Taro - Hawthorne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 430 participants |
| Start Date | 2023-12-04 |
| Est. Completion | 2024-02-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06305637
The ClinicalTrials.gov registry entry for NCT06305637 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 430 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sun Pharmaceutical Industries, which has 48 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tinea Versicolor appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT06305637 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06305637 about?
NCT06305637 is a clinical study titled "A Study Comparing Ketoconazole Shampoo, 2% and Ketoconazole 2% Shampoo (RS) in the Treatment of Tinea Versicolor.". To demonstrate the efficacy, therapeutic equivalence and safety of Ketoconazole Shampoo, 2% (Taro Pharmaceuticals U.S.A., Inc.) and Ketoconazole 2% Shampoo (Reference Standard) in the treatment of tinea versicolor.
What is the current status of trial NCT06305637?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 430 participants. The study started on 2023-12-04. Estimated completion is 2024-02-10.
What conditions does trial NCT06305637 study?
This clinical trial studies the following conditions: Tinea Versicolor.
What interventions are being tested in trial NCT06305637?
The interventions under investigation include: Placebo (DRUG), Ketoconazole Shampoo, 2% (DRUG), Ketoconazole Shampoo, 2% (Reference Standard) (DRUG).
Who is sponsoring clinical trial NCT06305637?
This trial is sponsored by Sun Pharmaceutical Industries, which has 48 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06305637 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.